🧐 ProPicks AI October update is out now! See which stocks made the listPick Stocks with AI

Zelira Therapeutics Ltd (ZLD)

Sydney
Currency in AUD
Disclaimer
0.720
+0.020(+2.86%)
Delayed Data
ZLD Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
Fair Value
Day's Range
0.7100.750
52 wk Range
0.2801.103
Bid/Ask
0.755 / 0.80
Prev. Close
0.7
Open
0.71
Day's Range
0.71-0.75
52 wk Range
0.28-1.103
Volume
2,893
Average Volume (3m)
7,429
1-Year Change
-27.55%
Fair Value
Unlock
Fair Value Upside
Unlock
ZLD Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins
Show more

Zelira Therapeutics Ltd Company Profile

Zelira Therapeutics Limited, a biopharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based medicines for the treatment of a variety of medical conditions in Australia and the United States. It offers formulations under the HOPE brand in Australia, Washington, Pennsylvania, and Louisiana, as well as develops Zenivol, a cannabinoid drug for the treatment of chronic insomnia. The company also provides over the counter products, including SprinJene, an oral care product; and acne treatment products under the RAF FIVE name, as well as Zyraydi, an enhanced distillate capture and dissolution matrix technology. In addition, it offers products for autism and chronic noncancer pain. The company was formerly known as Zelda Therapeutics Limited and changed its name to Zelira Therapeutics Limited in December 2019. Zelira Therapeutics Limited was incorporated in 2003 and is headquartered in Perth, Australia.

Compare ZLD to Peers and Sector

Metrics to compare
ZLD
Peers
Sector
Relationship
P/E Ratio
−0.2x−3.7x−0.6x
PEG Ratio
0.000.010.00
Price/Book
−1.7x3.1x2.6x
Price / LTM Sales
82.5x5.6x3.2x
Upside (Analyst Target)
-88.9%48.4%
Fair Value Upside
Unlock3.3%6.8%Unlock

FAQ

What Is the Zelira Therapeutics (ZLD) Stock Price Today?

The Zelira Therapeutics stock price today is 0.72

What Stock Exchange Does Zelira Therapeutics Trade On?

Zelira Therapeutics is listed and trades on the Sydney stock exchange.

What Is the Stock Symbol for Zelira Therapeutics?

The stock symbol for Zelira Therapeutics is "ZLD."

What Is the Zelira Therapeutics Market Cap?

As of today, Zelira Therapeutics market cap is 8.17M.

What is Zelira Therapeutics Earnings Per Share?

The Zelira Therapeutics EPS is -3.22.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.